An Open-Label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT).

Trial Profile

An Open-Label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT).

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2014

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms SPRINT
  • Sponsors The Medicines Company
  • Most Recent Events

    • 30 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 30 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jan 2009 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top